These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6060118)

  • 1. Long-term trial of local guanethidine in treatment of eye signs of thyroid dysfunction and idiopathic lid retraction.
    Crombie AL; Lawson AA
    Br Med J; 1967 Dec; 4(5579):592-5. PubMed ID: 6060118
    [No Abstract]   [Full Text] [Related]  

  • 2. Critical study of 5 per cent guanethidine in ocular manifestations of Graves's disease.
    Cartlidge NE; Crombie AL; Anderson J; Hall R
    Br Med J; 1969 Dec; 4(5684):645-7. PubMed ID: 4902494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guanethidine drops in thyroid eye disease.
    Millar GT
    Trans Ophthalmol Soc U K (1962); 1969; 88():677-9. PubMed ID: 5272285
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of guanethidine eye drops in dysthyroid lid retraction.
    Martin B; Jay B
    Proc R Soc Med; 1969 Jan; 62(1):18-9. PubMed ID: 5763459
    [No Abstract]   [Full Text] [Related]  

  • 5. Adrenergic blocking agents. A double-blind trial in the treatment of the eye signs of thyroid disorders.
    Crombie AL; Lawson AA
    Br J Ophthalmol; 1968 Aug; 52(8):616-20. PubMed ID: 4881690
    [No Abstract]   [Full Text] [Related]  

  • 6. Unwanted pharmacological effects of local guanethidine in the treatment of dysthyroid upper lid retraction.
    Cant JS; Lewis DR
    Br J Ophthalmol; 1969 Apr; 53(4):239-45. PubMed ID: 5818670
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of dysthyroid ophthalmopathy with local guanethidine.
    Cant JS; Lewis DR; Harrison MT
    Br J Ophthalmol; 1969 Apr; 53(4):233-8. PubMed ID: 5818669
    [No Abstract]   [Full Text] [Related]  

  • 8. [Action of 5 per cent guanethidine sulfate (ismeline) eye drops on lid retraction during Basedow's disease].
    Storch J
    Ann Ocul (Paris); 1971 Jun; 204(6):627-44. PubMed ID: 5109312
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of guanethidine eyedrops on the ocular manifestations of Basedow's disease].
    Berkman N; Joseph E
    Arch Ophtalmol Rev Gen Ophtalmol; 1971; 31(8):617-28. PubMed ID: 4256931
    [No Abstract]   [Full Text] [Related]  

  • 10. The interactions of local guanethidine and sympathomimetic amines in the human eye.
    Sneddon JM; Turner P
    Arch Ophthalmol; 1969 May; 81(5):622-7. PubMed ID: 5781738
    [No Abstract]   [Full Text] [Related]  

  • 11. Guanethidine ophthalmic solution 5 per cent. Use in the treatment of endocrine exophthalmos.
    Asregadoo ER
    Arch Ophthalmol; 1970 Jul; 84(1):21-4. PubMed ID: 4912585
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ocular manifestations of Basedow's disease and local administration of guanethidine].
    Berkman N; Joseph E
    Presse Med (1893); 1971 Jan; 79(3):83-6. PubMed ID: 5107433
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experiences with guanethidine in the treatment of hyperthyroidism].
    Laubinger G
    Med Welt; 1967 May; 21():1316-9. PubMed ID: 5612543
    [No Abstract]   [Full Text] [Related]  

  • 14. Local application of guanethidine in lagophthalmos.
    Grósz I
    Ther Hung; 1970; 18(2):83-4. PubMed ID: 5478799
    [No Abstract]   [Full Text] [Related]  

  • 15. Dysthyroid eye disease. A trial of guanethidine eye drops.
    Bowden AN; Rose FC
    Br J Ophthalmol; 1969 Apr; 53(4):246-51. PubMed ID: 4889097
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ismelin eye drops in glaucoma patients. Tonometric study].
    Filho Carvalho HP
    Hospital (Rio J); 1970 Mar; 77(3):865-71. PubMed ID: 5315116
    [No Abstract]   [Full Text] [Related]  

  • 17. Mueller's muscle: to relax or to incise.
    Haddad HM
    Metab Pediatr Syst Ophthalmol (1985); 1995; 18(1-4):15-8. PubMed ID: 9064490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Permanent improvement of thyroid-related upper eyelid retraction from bethanidine.
    Skinner SW; Miller JE
    Am J Ophthalmol; 1969 May; 67(5):764-6. PubMed ID: 5769812
    [No Abstract]   [Full Text] [Related]  

  • 19. GUANETHIDINE AND PUPILLARY REACTION.
    DORIAN W; SCHIRMER KE
    Can Med Assoc J; 1964 Apr; 90(15):932-3. PubMed ID: 14139993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. THYROID EYE-SIGNS IN NEPHROTIC SYNDROME: A SIDE-EFFECT OF STEROID THERAPY?
    OPIE WH; OPIE LH
    S Afr Med J; 1965 Jul; 39():577-9. PubMed ID: 14338514
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.